Joseph A Galanko
Overview
Explore the profile of Joseph A Galanko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
3968
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adler J, Galanko J, Ammoury R, Benkov K, Bousvaros A, Boyle B, et al.
Am J Gastroenterol
. 2024 Oct;
PMID: 39423015
Objectives: HLA DQA1*05 has been associated with the development of anti-drug antibodies (ADA) to tumor necrosis factor antagonists (anti-TNF) and treatment failure among adults with Crohn's disease (CD). However, findings...
2.
Moses J, Adler J, Saeed S, Firestine A, Galanko J, Ammoury R, et al.
Inflamm Bowel Dis
. 2024 Oct;
PMID: 39418336
Background: Higher drug levels and combination therapy with low-dose oral methotrexate (LD-MTX) may reduce anti-tumor necrosis factor (TNF) treatment failure in pediatric Crohn's disease. We sought to (1) evaluate whether...
3.
Marler J, Fujii C, Utley M, Balbierz D, Galanko J, Utley D
JMIR Form Res
. 2024 Sep;
8:e57376.
PMID: 39331522
Background: In the United States, e-cigarettes, or vapes, are the second most commonly used tobacco product. Despite abundant smartphone app-based cigarette cessation programs, there are few such programs for vaping...
4.
High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's Disease
Ebach D, Jester T, Galanko J, Firestine A, Ammoury R, Cabrera J, et al.
Am J Gastroenterol
. 2024 Mar;
119(6):1110-1116.
PMID: 38445644
Introduction: Obesity is common among patients with pediatric Crohn's disease (PCD). Some adult studies suggest obese patients respond less well to anti-tumor necrosis factor (TNF) treatment. This study sought compares...
5.
Marler J, Fujii C, Utley M, Balbierz D, Galanko J, Utley D
JMIR Mhealth Uhealth
. 2023 Aug;
11:e48157.
PMID: 37585282
Background: Increased smartphone ownership has led to the development of mobile smoking cessation programs. Although the related body of evidence, gathered through the conduct of randomized controlled trials (RCTs), has...
6.
Kelly C, Jawahar J, Davey L, Everitt J, Galanko J, Anderson C, et al.
mBio
. 2023 Aug;
14(4):e0150423.
PMID: 37526424
The inflammatory bowel diseases (IBD) occur in genetically susceptible individuals who mount inappropriate immune responses to their microbiota leading to chronic intestinal inflammation. Whereas IBD clinical presentation is well described,...
7.
Dellon E, Peterson K, Mitlyng B, Iuga A, Bookhout C, Cortright L, et al.
Gut
. 2023 Jul;
72(10):1828-1837.
PMID: 37423717
Objective: We aimed to determine whether mepolizumab, an anti-IL-5 antibody, was more effective than placebo for improving dysphagia symptoms and decreasing oesophageal eosinophil counts in eosinophilic oesophagitis (EoE). Methods: We...
8.
Kappelman M, Wohl D, Herfarth H, Firestine A, Adler J, Ammoury R, et al.
Gastroenterology
. 2023 Apr;
165(1):149-161.e7.
PMID: 37004887
Background & Aims: Tumor necrosis factor inhibitors, including infliximab and adalimumab, are a mainstay of pediatric Crohn's disease therapy; however, nonresponse and loss of response are common. As combination therapy...
9.
Marler J, Fujii C, Utley M, Balbierz D, Galanko J, Utley D
JMIR Mhealth Uhealth
. 2022 Oct;
10(11):e41658.
PMID: 36257323
Background: Cigarette smoking remains the leading cause of preventable illness and death, underscoring ongoing need for evidence-based solutions. Pivot, a US Clinical Practice Guideline-based mobile smoking cessation program, comprises a...
10.
Peery A, Keku T, Galanko J, Sandler R
Gastro Hep Adv
. 2022 Jul;
1(4):659-665.
PMID: 35821706
Background And Aims: Symptomatic uncomplicated diverticular disease is a controversial diagnosis defined as chronic gastrointestinal symptoms in patients with diverticulosis. We assessed whether individuals with diverticulosis had an increased risk...